[A practitioner's perspective of the latest lipid guidelines]

Area of Science:

• Cardiology
• Preventive Medicine
• Clinical Practice Guidelines

Background:

• The European Society of Cardiology (ESC) periodically updates cardiovascular disease (CVD) prevention guidelines.
• Previous guidelines focused on general risk assessment, but recent evidence highlights the need for tailored approaches based on specific patient profiles.

Purpose of the Study:

• To summarize the key updates and new concepts introduced in the latest ESC recommendations for cardiovascular risk management.
• To highlight the revised approach to stratifying patients and setting lipid-lowering targets.

Main Methods:

• Review of the latest published ESC guidelines on cardiovascular disease prevention.
• Analysis of the proposed new risk calculation tools (SCORE2 and SCORE2-OP).
• Examination of the differentiated low-density lipoprotein cholesterol (LDL-C) targets based on patient risk categories.

Main Results:

• The guidelines differentiate between apparently healthy individuals and those with specific cardiovascular risks (e.g., diabetes, renal failure, familial hypercholesterolemia).
• New risk assessment tools, SCORE2 and SCORE2-OP, are introduced.
• Specific LDL-C targets are proposed: generally < 1.8 mmol/l for high-risk and < 1.4 mmol/l for very-high-risk individuals.
• Therapeutic strategies incorporate risk modifiers, comorbidities, and patient preferences, emphasizing lifestyle optimization and statin therapy.

Conclusions:

• The updated ESC recommendations offer a more personalized approach to cardiovascular risk management.
• Clinicians should utilize the new risk scores and tailored LDL-C targets for effective patient care.
• Integrating patient-specific factors is crucial for optimizing lifestyle and pharmacological interventions.